Neurim Can't Stop Mylan From Restarting Melatonin Fight - Law360

Generic-drug maker Mylan is free to challenge the validity of Israeli pharmaceutical company Neurim's melatonin patent at an upcoming trial after a London judge ruled Monday that it did not run afoul of procedural rules about the timing of an...